MDRNA makes appointments to scientific advisory board
This article was originally published in Scrip
Executive Summary
MDRNA, a biotechnology company developing and commercialising therapeutic products based on RNAi, has appointed Dr Beverly Davidson and Dr Carl Novina to its scientific advisory board. Dr Davidson is professor of medicine, neurology and physiology and biophysics in the department of internal medicine at the University of Iowa, while Dr Novina is an assistant professor in the department of pathology at Harvard Medical School, an assistant professor of cancer immunology/AIDS at Dana-Farber Cancer Institute and an associate member at the Broad Institute.